TRUADVICE’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $126K | Buy |
3,339
+291
| +10% | +$11K | 0.05% | 229 |
|
|
2023
Q2 | $138K | Sell |
3,048
-318
| -9% | -$14.4K | 0.05% | 259 |
|
|
2023
Q1 | $165K | Buy |
+3,366
| New | +$165K | 0.07% | 249 |
|
|
2021
Q3 | – | Sell |
-41,261
| Closed | -$3.65M | – | 189 |
|
|
2021
Q2 | $3.65M | Buy |
41,261
+7,700
| +23% | +$682K | 0.8% | 29 |
|
|
2021
Q1 | $3.07M | Buy |
+33,561
| New | +$3.07M | 0.91% | 24 |
|